Pratley, Richard E.

Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC

Mishra, R., Åkerlund, M., Cousminer, D. L., Ahlqvist, E., Bradfield, J. P., Chesi, A., Hodge, K. M., Guy, V. C., Brillon, D. J., Pratley, R. E., et al. (2020) · Diabetes Care

Diabetes and associated disordersGenetic Associations and Epidemiology

Cited by 46

Erratum. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Suppl. 1):S158–S178

American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 45

The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials

Leiter, L. A., Bain, S. C., Bhatt, D. L., Buse, J. B., Mazer, C. D., Pratley, R. E., Rasmussen, S., Ripa, M. S., Vrazic, H., & Verma, S. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 45

Automated insulin delivery in older adults with type 1 diabetes

Kudva, Y. C., Henderson, R. J., Kanapka, L. G., Weinstock, R. S., Rickels, M. R., Pratley, R. E., Chaytor, N., Janess, K., Desjardins, D., Pattan, V., et al. (2025) · NEJM Evidence

Diabetes Management and ResearchDiabetes Management and Education

Cited by 45

Exaggerated insulin secretion in Pima Indians and African-Americans but higher insulin resistance in Pima Indians compared to African-Americans and Caucasians

Stefan, N., Stumvoll, M., Weyer, C., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2004) · Diabetic Medicine

Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 44

Hypoglycemia and glycemic control in older adults with type 1 diabetes: baseline results from the WISDM study

Carlson, A. L., Kanapka, L. G., Miller, K. M., Ahmann, A. J., Chaytor, N. S., Fox, S., Kiblinger, L., Kruger, D., Levy, C. J., Peters, A. L., et al. (2021) · Journal of Diabetes Science and Technology

Diabetes Management and ResearchDiabetes Management and Education

Cited by 43

Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial

Dagogo-Jack, S., Pratley, R. E., Cherney, D. Z. I., McGuire, D. K., Cosentino, F., Shih, W. J., Liu, J., Frederich, R., Mancuso, J. P., Raji, A., et al. (2021) · BMJ Open Diabetes Research & Care

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 37

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

Pratley, R. E., Husain, M., Lingvay, I., Pieber, T. R., Mark, T., Saevereid, H. A., Møller, D. V., Zinman, B., & the DEVOTE Study Group (2019) · Cardiovascular Diabetology

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 25

GIP: An Inconsequential Incretin or Not?

Pratley, R. E. (2010) · Diabetes Care

Diabetes Treatment and ManagementPancreatic function and diabetes

Cited by 19

Glycaemic outcomes of an Individualized treat Ment a Pproach for old ER vulnerable pat Ients: Arandomized, controlled st Udy in type 2 diabetes Mellitus ( IMPERIUM )

Heller, S. R., Pratley, R. E., Sinclair, A., Festa, A., Kiljański, J., Brusko, C. S., Duan, R., & Heine, R. J. (2018) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 18

Reproducibility of a prediabetes classification in a contemporary population

Chadha, C., Pittas, A. G., Lary, C. W., Knowler, W. C., Chatterjee, R., Phillips, L. S., Aroda, V. R., Lewis, M. R., Pratley, R., Staten, M. A., et al. (2020) · Metabolism Open

Diabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 15

Effects of newer anti-hyperglycemic agents on cardiovascular outcomes in older adults: systematic review and meta-analysis

Bilal, A., Yi, F., Gonzalez, G. R., Ali, M., Im, K., Ruff, C. T., Thethi, T. K., & Pratley, R. E. (2024) · Journal of Diabetes and its Complications

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 14

Palmitate oxidation rate and action on glycogen synthase in myoblasts from insulin-resistant subjects

Mott, D. M., Hoyt, C., Caspari, R., Stone, K., Pratley, R., & Bogardus, C. (2000) · American Journal of Physiology-Endocrinology and Metabolism

Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 13

Reduced glucose variability with glucose-dependent versus glucose-independent therapies despite similar glucose control and hypoglycemia rates in a randomized, controlled study of older patients with type 2 diabetes mellitus

Pratley, R. E., Rosenstock, J., Heller, S. R., Sinclair, A., Heine, R. J., Kiljański, J., Brusko, C. S., Duan, R., & Festa, A. (2018) · Journal of Diabetes Science and Technology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 13

Automated insulin delivery in elderly with type 1 diabetes: a prespecified analysis of the extension phase

Kudva, Y. C., Henderson, R. J., Kanapka, L. G., Weinstock, R. S., Rickels, M. R., Pratley, R. E., Chaytor, N., Janess, K., Desjardins, D., Pattan, V., et al. (2025) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchDiabetes Management and Education

Cited by 7